Literature DB >> 15911215

Biphasic accumulation kinetics of [99mTc]-hexakis-2-methoxyisobutyl isonitrile in tumour cells and its modulation by lipophilic P-glycoprotein ligands.

Teréz Márián1, László Balkay, Gábor Szabó, Zoárd T Krasznai, Zoltán Hernádi, László Galuska, Judit Szabó-Péli, Olga Esik, Lajos Trón, Zoltán Krasznai.   

Abstract

AIM: To study the accumulation and washout kinetics of [99mTc]-hexakis-2-methoxyisobutyl isonitrile (99mTc-MIBI) in MDR positive and MDR negative tumour cells and how this is modified by lipophilic P-glycoprotein ligands.
METHODS: The tumour cells were incubated in the presence and absence of the ligands and the uptakes of 99mTc-MIBI, rhodamine 123 and 2-[18F]fluoro-2-deoxy-D-glucose (18FDG) were measured.
RESULTS: The accumulation of 99mTc-MIBI in the tumour cells followed biphasic kinetics. Verapamil and cyclosporin A increased the membrane fluidity and significantly enhanced the 99mTc-MIBI uptake of the MDR negative cells, while the rhodamine 123 uptake was not affected. Verapamil significantly increased the uptake of rhodamine 123 and 18FDG but did not modify that of 99mTc-MIBI in the MDR positive cells. Cyclosporin A significantly increased the 18FDG uptake of the MDR positive and negative tumour cells; these effects were ouabain-sensitive. Depolarization of the cytoplasmic membrane, acidification of the extracellular medium and the administration of CCCP decreased the accumulation of 99mTc-MIBI and rhodamine 123 uptake in the tumour cells.
CONCLUSIONS: Lipophilic P-glycoprotein ligands modified the biphasic accumulation kinetics of the 99mTc-MIBI uptakes of MDR negative and positive tumour cells in different and complex ways and could therefore mask the P-glycoprotein pump-dependent changes in tracer accumulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911215     DOI: 10.1016/j.ejps.2005.02.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

1.  Pulmonary elimination rate of inhaled 99mTc-sestamibi radioaerosol is delayed in healthy cigarette smokers.

Authors:  Prina Ruparelia; Heok K Cheow; John W Evans; Leith Banney; Sonal Shankar; Katherine R Szczepura; Anna E Swift; James R Ballinger; Neil G Hartman; Edwin R Chilvers; A Michael Peters
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

Review 2.  Imaging of multidrug resistance in cancer.

Authors:  S Dizdarevic; A M Peters
Journal:  Cancer Imaging       Date:  2011-03-01       Impact factor: 3.909

3.  Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells.

Authors:  Fang Wang; Yifan Chen; Lihua Huang; Tao Liu; Yue Huang; Jianming Zhao; Xiaokun Wang; Ke Yang; Shaolin Ma; Liyan Huang; Kenneth Kin Wah To; Yong Gu; Liwu Fu
Journal:  Oncotarget       Date:  2015-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.